Cannabinol (CBN) is a mildly psychoactive cannabinoid formed by the oxidative degradation of THC. When THC is exposed to air, light, and heat over time, it converts progressively to CBN. This is why aged cannabis produces different effects than fresh cannabis — the THC-to-CBN ratio shifts. CBN is present at low levels in most cannabis preparations but has become a focus of product development, particularly in the sleep category.
The Pharmacology of CBN
CBN is a weak CB1 receptor partial agonist — significantly less potent than THC at CB1, which accounts for its mild psychoactivity relative to THC. It also acts at CB2 receptors, PPARγ (a nuclear receptor involved in metabolism and inflammation), and demonstrates affinity for several other targets including TRP channels involved in pain and temperature regulation.
Sedation: What the Research Actually Shows
The 'CBN is sedating' claim traces back primarily to a 1975 Psychopharmacologia study that found CBN combined with THC produced greater sedation than THC alone. The study did not test CBN in isolation. This finding — CBN as a THC potentiator — was long interpreted as evidence that CBN itself is sedating, which is not what the study demonstrated.
More recent research has produced conflicting findings. A 2021 industry-funded study found participants fell asleep faster and stayed asleep longer with CBN — but the study lacked a placebo control. The sedation question for CBN in isolation remains scientifically open. What is more clearly established is that CBN, in combination with other cannabinoids, modulates sleep through multiple indirect mechanisms.
Pain and Inflammation
CBN has been studied in pain contexts more definitively. A 2019 study in Archives of Oral Biology found CBN to be effective at reducing the sensitization of masticatory muscles — relevant to conditions like temporomandibular joint dysfunction and bruxism. A 2021 study in Pain demonstrated CBN could decrease pain sensitivity through a TRPA1-mediated mechanism.
Antibacterial Activity
Like CBG, CBN has demonstrated antibacterial properties against resistant organisms. Research by McMaster University included CBN among the cannabinoids showing efficacy against MRSA, suggesting a class-level property of certain cannabinoids rather than unique to any single compound.
Appetite Stimulation
A 2012 study in Psychopharmacology found CBN to be as effective as THC in increasing food consumption in rats — relevant for applications in appetite stimulation in cancer care, eating disorders, or cachexia.
I've tried melatonin, magnesium, and every sleep protocol in existence. CBN in combination with a small amount of CBD is the first thing that's improved my sleep quality — I stay asleep instead of waking at 3 AM. — CBN consumer, 52, Chicago
The Real Story: The Entourage Effect and Sleep
The most credible mechanism by which CBN-containing products improve sleep is likely through synergistic interaction with other cannabinoids and terpenes — the entourage effect. Terpenes like myrcene, linalool, and bisabolol present in full-spectrum preparations have established sleep-modulating properties. The combination of weak CB1 agonism, TRPA1 activity, and terpene synergy creates a sleep-supportive profile that pure CBN or pure CBD alone may not fully replicate.
For formulators, this means CBN is most compelling in full-spectrum or targeted cannabinoid blend products rather than as a single-ingredient isolate product. Products combining CBN with CBG, CBD, and sleep-supportive terpenes represent the leading edge of formulation in this space.